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Several prospective epidemiological studies on large cohorts have consistently reported
an association between milk intake and a higher incidence of Parkinson’s disease (PD).
Pesticide contamination of milk and milk’s urate-lowering effects have been put forward as
risk factors to explain epidemiological data.This has led to considerable uncertainty among
physicians and avoidance of dairy products by PD patients. However, neither factor stands
up to the rational and detailed examination of the literature carried out in this mini-review.
We suggest that changes in eating behavior related to pre-motor PD are an alternative
potential explanation of correlations observed between milk intake and PD occurrence.
Despite clear-cut associations between milk intake and PD incidence, there is no rational
explanation for milk being a risk factor for PD. Based on current knowledge, limiting the
consumption of dairy products does not seem to be a reasonable strategy in the prevention
of the development and progression of PD.
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INTRODUCTION
Parkinson’s disease (PD) is a neurodegenerative disease, charac-
terized by a progressive loss of dopaminergic neurons originating
in the Substantia nigra pars compacta. The etiology is unknown,
and environmental factors are thought to play a role in neuro-
toxicity, especially factors contributing to oxidative stress, such as
pesticides or heavy metals (1). Dietary factors may be relevant as
they can alter the redox balance in the brain or serve as a vehicle
for environmental neurotoxins. Data from prospective epidemio-
logical research has made the study of any link between PD and
dietary factors possible. One such finding, recently recapitulated
in a meta-analysis (2), was a positive association between milk
intake and PD risk. Due to speculation and warnings in the lay
press, on the internet and from physicians, many PD patients tend
to avoid dairy products. This precaution may worsen the quality
of their diet, especially that of elderly patients, who are at risk of
under-nutrition, loss of weight and muscle mass (3), osteoporosis
(4), and hip fracture (5).
DAIRY PRODUCTS IN NUTRITION
Most milk products consumed in human nutrition come from
cow’s milk. The significance of milk in human nutrition is related
to its content in protein (3%), fat (3–4%), carbohydrate (lactose)
(4–5%), calcium (1200 mg/L), and other minerals, microelements,
and vitamins (6). The protein fraction is of high quality in terms
of digestibility and amino acid composition (6) and encourages
skeletal muscle growth (7), which contributes to the prevention of
sarcopenia, especially in the elderly.
Bioactive peptides resulting from enzymatic hydrolysis of milk
proteins exert multiple biological – such as immunomodulatory
and antihypertensive – actions, and are thought to play a protec-
tive role in human health (6). Milk and dairy products are the
most important sources of calcium in human nutrition and their
consumption is related to higher bone density, which may con-
tribute to osteoporosis prevention (6, 8). Consumption of dairy
products is also associated with improved metabolic health, and
epidemiological evidence points to the contribution of milk in the
prevention of metabolic disorders such as excess weight, type 2
diabetes, and cardiovascular disease (7).
Global recommended adult dietary calcium allowances range
from 700 to 1300 mg/day (7) and milk products are a good source
of calcium with high bioavailability. Because of their nutritional
values, dairy products are highly recommended, especially for
older people (6–8) and special recommendations also exist for
ethnic groups with a high prevalence of lactose intolerance (9).
DAIRY PRODUCTS AND PD RISK: EPIDEMIOLOGICAL DATA
A positive association between milk consumption and PD risk has
been found in large prospective cohort studies in the United States,
Finland and Greece (10–14) (Table 1). A recent meta-analysis
reported a combined risk of 1.4 for highest vs. lowest levels of
dairy food intake, with a stronger association for men than for
women (2).
Overall, the association between PD and milk was stronger than
the association with other dairy products such as cheese, yogurt, or
butter (2). We do not know which of the components of milk medi-
ates this effect. It is unlikely to be due to milk compounds such as
calcium, vitamin D, total fat, or total protein as these compounds
are not associated with PD when derived from other sources (11,
14). It was hypothesized that low levels of pesticides or other neu-
rotoxic chemicals may be present in milk and could accumulate
in the brain and increase PD risk (15). However, this hypothesis is
rather unlikely as skimmed products containing less fat, and there-
fore a decreased capacity for harboring pesticides, have the same
effect (12). Meta-analysis of existing studies (2) has shown that
the link between butter and the risk of PD is even lower. Park et al.
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Table 1 | Consumption of dairy products and incidence of PD.
Reference Study cohort origin n/PD cases Follow-up (years) Findings
Chen et al. (14) HPFSa+NHSa USA 135894/394 18–22 Positive association: milk and PD (men>women)
Park et al. (11) Honolulu Heart Program USA/J 7504/128 30 Positive association milk and PD (men) but no
association with Calcium, total fat, protein, cheese,
butter, ice-cream
Chen et al. (13) CPSa II Nutrition cohort USA 130867/388 9 Positive association: dairy products and PD
(men>women), milk>dairy products
Kyrozis et al. (10) Prospective cohort (EPICa) Greece 26173/120 8 Positive association milk, but no association with
cheese and yogurt
Sääksjärvi et al. (12) Finnish Mobile Clinic Survey Finland 4524/85 41 Milk (women)
aNHS, National Health Study; HPFS, health professional follow-up study; EPIC, European Prospective Investigation into Cancer and Nutrition; CPS, Cancer Prevention
Study.
speculated that genetic characteristics, such as lactose intolerance
could be protective. However, the association between milk intake
and PD persisted after men who consumed no milk whatsoever
(presumably those with lactose intolerance) were excluded (11).
Another theory points to a milk-induced shift in the metabolic
redox balance: it was shown that ingestion of milk can decrease
serum urate levels in healthy volunteers (16). Urate is a potent
endogenous antioxidant, which can inactivate potentially harmful
neurotoxic substances, such as free radicals or iron (17). A recent
meta-analysis confirmed low urate levels in PD, a finding, which
could point to a neuro-protective role of urate (18).
However, we lack evidence of either (a) a role of low urate lev-
els in neuro-degeneration or (b) an association between milk and
metabolic antioxidative defense.
CONSUMPTION OF DAIRY PRODUCTS IN PRE-MOTOR PD:
A RESULT OF ALTERED EATING BEHAVIOR?
We hypothesize that psychological and emotional alteration in
pre-motor PD may induce modifications in eating behavior. Non-
motor symptoms, such as depression, anxiety, or apathy may be
present in PD and precede motor symptoms (19). Associations
between foods and moods, especially depressive symptoms, have
been reported (20, 21). But why would these patients prefer milk
to all other foods? One possible hypothesis is that milk consump-
tion could be associated with mood alterations, as has been shown
in an Australian epidemiologic study, where consumption of dairy
products was related to the presence of depressive symptoms (22).
This could be linked to alpha-lactalbumin, one of the main protein
components of milk, which is rich in tryptophan, the precursor of
serotonin. Serotonergic hypofunction has been described in early
PD and may be involved in depression and anxiety (23). A signif-
icant rise in cortex tryptophan closely followed by an increase
of serotonin synthesis occurred in rats following acute alpha-
lactalbumin consumption (24) and this effect persisted chronically
(25). In human volunteers an alpha-lactalbumin-enriched diet
increases the ratio of tryptophan to the other large neutral amino
acids, which is considered to be an indirect indication of increased
brain serotonin function (26). In stress-vulnerable individuals,
alpha-lactalbumin improved mood and attenuated the cortisol
response following experimental stress (26). In individuals with
high-trait anxiety, the administration of alpha-lactalbumin had
an effect on food hedonics (27). Milk consumption in pre-motor
PD may therefore be interpreted as spontaneous self-medication
aimed at improving mood. Since the effect would be very discreet,
it would only be observed in large-scale epidemiological stud-
ies. This hypothesis might also explain why milk is more strongly
linked to PD than cheese: In the cheese-making process, the liquid
whey containing alpha-lactalbumin is separated from the curd,
and cheese does not contain alpha-lactalbumin.
Furthermore, in many Western countries, milk is traditionally
considered as a sleep-inducing beverage and could be consumed –
because of its content in melatonin or just on belief – by people suf-
fering from sleep disorders (28), which are frequent in pre-motor
PD (29).
However, as we have no strong evidence of the mood- or sleep-
modifying effects of milk to date, other mechanisms should be
considered to explain the epidemiological findings. Other non-
motor symptoms that are frequent in pre-motor PD, such as
hyposmia or constipation (30), for instance, may alter dietary
habits. Dairy foods, especially fermented products, may relieve
constipation, or constipated people may think they do. Another
hypothesis is increased consumption of dairy products secondary
to decreased consumption of other drinks. In fact, coffee con-
sumption was reported to be low in pre-motor PD (31) and may
have been replaced by dairy products. Finally, dopaminergic and
homeostatic control of eating behavior may be disturbed in pre-
motor PD (3), leading to alterations in dietary habits which may
explain the findings.
CONCLUSION
To date, the explanation for the epidemiological link between
dairy products and PD remains unknown. Evidence that milk
constitutes a risk factor in PD is lacking. Limitation of milk con-
sumption cannot therefore be recommended, just as smoking or
coffee drinking cannot be recommended in order to prevent PD.
Foods that supply calcium and high-quality protein should not
be limited in view of the high prevalence of osteoporosis and hip
fracture in PD (4, 5). Because of their high nutritional qualities,
consumption of milk and dairy products should be encouraged in
PD to the same degree as in the general population. Interference
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with dopaminergic treatment may be canceled out by respecting
appropriate time lags between medication intake and meals. In
the case of lactose intolerance, fermented dairy products, such as
yogurt or cheese, may replace milk.
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